Product Code: GVR-4-68040-120-8
Ultrasound Needle Guides Market Growth & Trends:
The global ultrasound needle guides market size is anticipated to reach USD 495.0 million by 2030, according to a new report by Grand View Research, Inc.. The market is expected to advance at a CAGR of 3.93% from 2023 to 2030. Factors such as the increasing number of regulatory approvals for biopsy systems and novel product launches drive industry growth. As ultrasound-guided procedures become more widely used, there is a growing focus on training and educating healthcare professionals to ensure the safe and efficient use of these instruments. The creation of simulation tools and training programs is an aspect of this development.
Moreover, the increasing application of artificial intelligence in ultrasound devices boosts market growth. The use of AI and machine learning can improve the efficiency of ultrasonic needle guides. The overall success rates of treatments can be raised by using AI algorithms to help with real-time picture analysis, needle trajectory prediction, and automatic changes based on patient anatomy.
For instance, in July 2023, with the introduction of Sonosite ST, FUJIFILM Sonosite, Inc. added to its already expansive range of systems. It features a brand-new 21-inch touchscreen with an all-touch interface, a sizable image area of 10" by 7.5", automated setup customization for every test type, Auto Steep Needle Profiling, and more. To support system reliability, Sonosite ST also belongs to the identical series of transducers as Sonosite LX and Sonosite PX. For the most frequently performed POCUS-guided procedures, such as vascular access in emergency medicine, nerve block delivery in regional anesthesia, and joint injections in musculoskeletal treatment, Sonosite ST offers optimum exam types.
Key industry players are involved in expanding their product portfolio with novel product launches, which boosts the market for ultrasound needle guides. For instance, in September 2022, by utilizing GE Healthcare's Vscan Air portable wireless ultrasound equipment, Intelligent Ultrasound introduced the 'NeedleTrainer 2', increasing the accessibility of ultrasound-guided needle training for medical practitioners. The live simulation tool 'NeedleTrainer' was created to help medical professionals learn coordination of the use of a needle and a probe during safe ultrasound-guided interventions.
The retractable needle used by NeedleTrainer can be used with computer-generated patches to simulate non-invasive needling on a live subject employing a live ultrasound scan. This makes it feasible for learners to practice ultrasound-guided interventional surgeries in a simulated clinical setting while improving their hand-eye coordination, appropriate placement, and accuracy without affecting patient care or endangering patient safety.
The increasing rate of regulatory approvals for biopsy systems drives industry growth. For instance, in October 2022, NeoDynamics AB, a medical device business specializing in cancer detection and treatment, launched the biopsy system 'NeoNavia', accompanied by the company's FlexiPulse probe, in the U.S. in order to assist in cancer diagnosis. The approval is expected to aid doctors in addressing critical issues that arise when treating and diagnosing breast cancer, including the precise identification of malignant tumors in the breast and their propagation outside of the breast.
The advantages associated with ultrasound-guided operations are becoming increasingly recognized by patients and healthcare professionals across the globe. Healthcare professionals are becoming more aware of the benefits of using ultrasound guidance to improve treatment results since patients frequently favor minimum invasive options.
Ultrasound Needle Guides Market Report Highlights:
- In 2022, the disposable segment dominated the market for ultrasound needle guides with a revenue share of 85.27%. In hospital settings, disposable needles are a vital part of infection control methods. They reduce the risk of infections brought on by needle reuse by doing away with the necessity for purification and disinfection
- Based on application, the regional anesthesia segment led the market with a revenue share of 29.41% in 2022. Some well-known advantages of regional anesthesia include a lower chance of general anesthetic-related problems, shorter healing times, and better postoperative pain control
- In terms of end-use, hospitals and clinics held a majority share of 41.53% of the market in 2022. Increasing number of patients being admitted to hospitals due to surgeries, therapies, and treatments is poised to drive the demand for ultrasound needle guides in the near future
- North America led the market with the highest revenue share of 29.68% in 2022. Rising demand for minimally invasive surgeries and growing government initiatives to improve healthcare infrastructure in the region are the key factors driving market growth. In addition, technological advancements will create lucrative opportunities for the regional segment
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Type
- 1.1.2. Application
- 1.1.3. End-use
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for Primary Interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Application outlook
- 2.2.3. End-use outlook
- 2.2.4. Regional outlook
- 2.2.5. Competitive Insights
Chapter 3. Ultrasound Needle Guides Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Reimbursement framework
- 3.4. Market Dynamics
- 3.4.1. Market Driver Analysis
- 3.4.1.1. Rising incidence of cancer cases.
- 3.4.1.2. Technological advancements in ultrasound technology
- 3.4.2. Market Restraint Analysis
- 3.4.2.1. Lack of skilled medical professionals
- 3.5. Ultrasound Needle Guides Market Analysis Tools
- 3.5.1. Industry Analysis - Porter's Five Forces
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat of new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic Landscape
- 3.5.3. Major Deals & Strategic Alliances Analysis
- 3.5.4. Market Entry Strategies
Chapter 4. Ultrasound Needle Guides Market: Type Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Reusable
- 4.1.2. Disposable
- 4.2. Type Market Share, 2018 & 2030
- 4.3. Segment Dashboard
- 4.4. Global Ultrasound Needle Guides Market by Type Outlook
- 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5.1. Reusable
- 4.5.1.1. Reusable market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.2. Disposable
- 4.5.2.1. Disposable market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Ultrasound Needle Guides Market: Application Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. Tissue Biopsy
- 5.1.2. Fluid Aspiration
- 5.1.3. Nerve Block
- 5.1.4. Regional Anesthesia
- 5.1.5. Vascular Access
- 5.1.6. Others
- 5.2. Application Market Share, 2018 & 2030
- 5.3. Segment Dashboard
- 5.4. Global Ultrasound Needle Guides Market by Application Outlook
- 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5.1. Tissue Biopsy
- 5.5.1.1. Tissue biopsy market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.2. Fluid Aspiration
- 5.5.2.1. Fluid aspiration market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.3. Nerve Block
- 5.5.3.1. Nerve block market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.4. Regional Anesthesia
- 5.5.4.1. Regional anesthesia market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.5. Vascular Access
- 5.5.5.1. Vascular access market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.6. Others
- 5.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Ultrasound Needle Guides Market: End-use Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.1.1. Hospitals & Clinics
- 6.1.2. Ambulatory Surgical Centers
- 6.1.3. Diagnostic Imaging Centers
- 6.1.4. Others
- 6.2. End-use Market Share, 2018 & 2030
- 6.3. Segment Dashboard
- 6.4. Global Ultrasound Needle Guides Market by End-use Outlook
- 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5.1. Hospitals & Clinics
- 6.5.1.1. Hospitals & clinics market estimates and forecast 2018 to 2030 (USD Million)
- 6.5.2. Ambulatory Surgical Centers
- 6.5.2.1. Ambulatory surgical centers market estimates and forecast 2018 to 2030 (USD Million)
- 6.5.3. Diagnostic Imaging Centers
- 6.5.3.1. Diagnostic imaging centers market estimates and forecast 2018 to 2030 (USD Million)
- 6.5.4. Others
- 6.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Ultrasound Needle Guides Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2022 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Regional Market Share and Leading Players, 2022
- 7.4.1. North America
- 7.4.2. Europe
- 7.4.3. Asia Pacific
- 7.4.4. Latin America
- 7.4.5. Middle East and Africa
- 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
- 7.5.1. North America
- 7.5.2. Europe
- 7.5.3. Asia Pacific
- 7.5.4. Latin America
- 7.5.5. Middle East and Africa
- 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030
- 7.7. North America
- 7.7.1. Market estimates and forecast, 2018 - 2030
- 7.7.2. U.S.
- 7.7.2.1. Market estimates and forecast, 2018 - 2030
- 7.7.3. Canada
- 7.7.3.1. Market estimates and forecast, 2018 - 2030
- 7.8. Europe
- 7.8.1. UK
- 7.8.1.1. Market estimates and forecast, 2018 - 2030
- 7.8.2. Germany
- 7.8.2.1. Market estimates and forecast, 2018 - 2030
- 7.8.3. France
- 7.8.3.1. Market estimates and forecast, 2018 - 2030
- 7.8.4. Italy
- 7.8.4.1. Market estimates and forecast, 2018 - 2030
- 7.8.5. Spain
- 7.8.5.1. Market estimates and forecast, 2018 - 2030
- 7.8.6. Sweden
- 7.8.6.1. Market estimates and forecast, 2018 - 2030
- 7.8.7. Denmark
- 7.8.7.1. Market estimates and forecast, 2018 - 2030
- 7.8.8. Norway
- 7.8.8.1. Market estimates and forecast, 2018 - 2030
- 7.9. Asia Pacific
- 7.9.1. Japan
- 7.9.1.1. Market estimates and Forecast, 2018 - 2030
- 7.9.2. China
- 7.9.2.1. Market estimates and forecast, 2018 - 2030
- 7.9.3. India
- 7.9.3.1. Market estimates and forecast, 2018 - 2030
- 7.9.4. South Korea
- 7.9.4.1. Market estimates and forecast, 2018 - 2030
- 7.9.5. Thailand
- 7.9.5.1. Market estimates and forecast, 2018 - 2030
- 7.9.6. Australia
- 7.9.6.1. Market estimates and forecast, 2018 - 2030
- 7.10. Latin America
- 7.10.1. Brazil
- 7.10.1.1. Market estimates and forecast, 2018 - 2030
- 7.10.2. Mexico
- 7.10.2.1. Market estimates and forecast, 2018 - 2030
- 7.10.3. Argentina
- 7.10.3.1. Market estimates and forecast, 2018 - 2030
- 7.11. MEA
- 7.11.1. South Africa
- 7.11.1.1. Market estimates and forecast, 2018 - 2030
- 7.11.2. Saudi Arabia
- 7.11.2.1. Market estimates and forecast, 2018 - 2030
- 7.11.3. UAE
- 7.11.3.1. Market estimates and forecast, 2018 - 2030
- 7.11.4. Kuwait
- 7.11.4.1. Market estimates and forecast, 2018 - 2030
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key Company Market Share Analysis, 2022
- 8.3.4. CIVCO Medical Solutions
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. BD
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. GEOTEK MEDICAL
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. JingFang Precision Medical Device (Shenzhen) Co., Ltd.
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Rocket Medical plc
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. GE HealthCare
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Mermaid Medical
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives